Assessment of heterogeneity and disease onset in the Parkinson’s Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional study

MLA

Andrew Siderowf, et al. Assessment of Heterogeneity and Disease Onset in the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the α-Synuclein Seed Amplification Assay: A Cross-Sectional Study. Mar. 2023. EBSCOhost, https://doi.org/10.1101/2023.02.27.23286156.

APA

Andrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, Carly M. Farris, Yihua Ma, Paula A. Urenia, Hieu Nguyen, Roy N. Alcalay, Lana M. Chahine, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, John Seibyl, Tanya Simuni, Caroline M. Tanner, Daniel Weintraub, … Claudio Soto. (2023). Assessment of heterogeneity and disease onset in the Parkinson’s Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional study. https://doi.org/10.1101/2023.02.27.23286156

Chicago

Andrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, Carly M. Farris, Yihua Ma, Paula A. Urenia, Hieu Nguyen, et al. 2023. “Assessment of Heterogeneity and Disease Onset in the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the α-Synuclein Seed Amplification Assay: A Cross-Sectional Study,” March. doi:10.1101/2023.02.27.23286156.